Impact of Cytokine Inhibitor Therapy on the Prevalence, Seroconversion Rate, and Longevity of the Humoral Immune Response Against SARS-CoV-2 in an Unvaccinated Cohort.

David Simon, Koray Tascilar, Arnd Kleyer, Filippo Fagni, Gerhard Krönke, Christine Meder, Peter Dietrich, Till Orlemann, Thorsten Kliem, Johanna Mößner, Anna-Maria Liphardt, Verena Schönau, Daniela Bohr, Louis Schuster, Fabian Hartmann, Moritz Leppkes, Andreas Ramming, Milena Pachowsky, Florian Schuch, Monika RonnebergerStefan Kleinert, Axel Hueber (Co-author), Karin Manger, Bernhard Manger, Raja Atreya, Carola Berking, Michael Sticherling, Markus F Neurath, Georg Schett

    Research output: Contribution to journalOriginal Article (Journal)peer-review

    8 Citations (Web of Science)
    Original languageEnglish
    Pages (from-to)783-790
    JournalARTHRITIS & RHEUMATOLOGY
    Volume74
    Issue number5
    DOIs
    Publication statusPublished - 2022

    Keywords

    • COVID-19

    Cite this